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ABSTRACT
Nitric oxide synthesis by chicken macrophages results in coordinated changes of multiple
arginine transporters
Michael Moulds
Arginine transport is primarily mediated by the cationic amino acid transporters (CATs) in
mammalian cells, but in aves the y+, b0,+ and B0,+ transport systems have also been observed.
Arginine is the limiting catabolic substrate required for the production of nitric oxide (NO), a
highly reactive compound that acts as a signaling molecule or killing compound. NO is
synthesized by inducible nitric oxide synthase (iNOS) by macrophages for pathogen clearance.
In mammals, CAT-2B is responsible for ARG import in the macrophage for NO synthesis, but
the chicken CAT-2B isoform does not transport ARG. Therefore the objective of these studies
was to identify the CAT(s) involved in mediating ARG uptake during a NO response in the
chicken macrophage. Experiments were performed to measure: 1) ARG transporter mRNA and
NO production from three sources of macrophages (HD11 cell line, n=6; primary 32d Cobb 500,
n=8; Hyline W36, n=7) in response to Escherichia coli lipopolysaccharide (LPS); 2) the effect of
CAT over-expression on NO production in response to LPS (HD11 cell line; n=8). In response to
LPS iNOS mRNA abundance increased (P<0.05) 8.5-fold in the HD11 macrophages, 3.22-fold
in broiler macrophages and 2.79-fold in layer macrophages. In all cells, CAT-1 was induced and
CAT-2A increased (P<0.05) between 1.28 and 1.68-fold. CAT-2B was not detected at any time
point or treatment condition. In the virally transformed chicken macrophage cell line (HD11)
CAT-3 mRNA was induced, but in primary cells CAT-3 increased (P<0.05) 1.27-fold in broilers
and 1.23-fold in layers. Transiently transfected chicken macrophages produce NO independent
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of LPS treatment by 6h, mock transfected controls did not respond by 6h. In the presence of LPS,
CAT-1 transfected macrophages produced 50.0% more NO than mock transfected cells (P<0.05).
CAT-2A and CAT-3 transfected macrophages produced only 17.6% and 72.1% of the total NO
produced by controls (P<0.05). These results indicate that CAT-1 and CAT-3 are both sufficient
to sustain ARG import for NO production in the chicken macrophage, but that CAT-1 produces a
maximal response. These results also show that iNOS, despite its name, is constitutively present
and can be activated by induction of CATs to import ARG.
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CHAPTER 1
Introduction
1.1. Overview of the Immune System
The immune system consists of innate and adaptive branches that provide non-specific,
broadly specific and highly specific responses to pathogens and antigens. These different
branches are coordinated through cytokine signaling and receptor-mediated immune cell
interactions [1, 2]. The innate branch of the immune system is constitutive and the first response
to pathogens or antigens. It acts using broadly specific or non-specific responses and recognizes
pathogens with via broadly specific pathogen associated molecular patterns [2, 3]. This innate
immune recognition does not alter or improve with repeat exposure [1]. In addition to
constitutive barriers like the skin and mucous membranes, the innate immune system includes
granulocytes (basophils, eosinophils, and neutrophils/heterophils), natural killer cells, dendritic
cells and macrophages/monocytes [3, 4]. Granulocytes each target a broad-type response, but
they are all phagocytic cells that contain granules of lytic enzymes and anti-microbial molecules.
Basophils mediate allergic responses and eosinophils target parasitic infections [3-5].
Neutrophils are involved in bacterial infections and are one of the first cell types to arrive in
response to cytokine release [3, 5]. Natural killer cells target a myriad of stressed cell types
including virally infected cells, tumor cells and damaged cells [6, 7]. Dendritic cells and
macrophages are phagocytic and antigen presenting cells that provide a link between innate and
adaptive immune responses [8-10].
The adaptive immune response is characterized by the development of antigen-specific
effector and memory cells [11]. It provides cell-mediated and humoral immunity with cytotoxic
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T lymphocytes, T helper (TH) cells and B cells [1, 3, 11]. Cytotoxic T lymphocytes target
intracellular pathogens and B cells target extracellular pathogens [3, 5]. B cells produce a wide
variety of immunoglobulins (Ig), or antibodies, in response to pathogen recognition or antigen
stimulation [3, 10, 12]. IgM is the first Ig secreted by B cells and is secreted as a pentamer [3, 5].
In generating a more targeted immune response, B cells also switch Ig type in addition to
undergoing receptor rearrangement [3, 5]. The most common isotype produced by activated
mature B cells is IgG, but others include IgA, IgD and IgE [3, 4]. IgA is a secretory antibody
produced in mucosal lymphoid tissue as a dimer [4]. IgE is produced in response to parasitic
infections and triggers the degranulation of mast cells during an allergic reaction. Many subtypes of TH cells augment the effector functions of both innate and adaptive immune cells
through the production of cytokines [1, 2, 11]. TH1 cells produce pro-inflammatory cytokines
including interferon- γ (IFN-γ) and aid in macrophage activation [13-16]. TH2 lymphocytes
produce interleukin-10 (IL-10) and transforming growth factor- β (TGF-β), cytokines that
stimulate B cells and increase antibody production [2, 3, 8]. TH17 cells are named for their
production of IL-17, a cytokine involved in neutrophil recruitment to the site of an infection [3,
5]. Both TH1 and TH2 cytokines are cross inhibitory, thus a TH1 type response prevents TH2 and
TH17; TH2 inhibits TH1 and TH17 activation [3]. Additionally, Treg cells maintain the inactive
state of TH cells through the production of TGF-β until they are down regulated [2, 3].
The tissues of the immune system are classified as primary or secondary lymphoid tissues
based on their function. Primary immune tissues are sites of lymphopoeisis and lymphocyte
maturation. B cells are produced and develop in the bone marrow of mammals and in the bursa
in aves; T cells develop in the thymus [3, 4, 11]. Lymphocytes leave primary lymphoid tissues as
self-tolerant mature naïve cells [11, 17]. Secondary lymphoid tissues such as the spleen, lymph
2

nodes and gut, bronchial, mucosal and cutaneous associated lymphoid tissues are where
lymphocytes encounter antigens [4]. These tissues are also the sites of lymphocyte proliferation,
Ig class switching and receptor hyper-variability [3, 5].
1.1.1 Macrophages
Macrophages, or activated monocytes, are phagocytic and antigen presenting cells of the
innate immune system, but they are also involved in wound healing and tumor suppression [1820]. Macrophages exist in peripheral blood as monocytes and become active once they leave
circulation, or extravasate, and enter tissue [8, 21, 22]. Primary macrophages isolated from tissue
and primary monocytes isolated from blood exhibit similar responses when activated. Both types
of cell isolates produce reactive nitrogen species, actively phagocytose, synthesize cytokines and
increase major histocompatibility II expression [23, 24]. Many specialized macrophages, or
macrophage-like cells, exist in numerous tissues including alveolar macrophages in the lungs,
Kupffer cells in the liver, microglial cells in the nervous tissue and osteoclasts in bone [25, 26].
Macrophages and macrophage-like cells recognize pathogens through the use of pattern
recognition receptors including mannose-binding lectin, the toll-like family of receptors (TLR),
antibody-antigen complexes and acute phase protein interactions [9, 10, 27-30]. Primary and cell
line macrophages behave as their in vivo counterparts through phagocytosis, antigen presentation
and cytokine production [10, 31]. The chicken macrophage cell line (HD11) is an immortalized
cell line that was virally transformed by the avian myelocytomatosis virus (MC29) [32]. The
MC29 virus creates tumors and immortalizes cells in part by altering the transcription factor myc
[33]. The differences between primary macrophages and HD11s, as a model for L-arginine
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(ARG) dependent nitric oxide (NO) production, remain similar despite 20 years of animal
breeding and continual culture [31].
The differences between primary macrophages and cell lines are complex and may or
may not accurately represent the in vivo immune response. While the HD11 cell line is a pure
population of macrophages and thus removes the interactions of contaminating cell types in
vitro, an in vivo immune challenge recruits neutrophils, TH cells, natural killer cells in addition to
circulating antibody and acute phase proteins [6, 34]. However, as a cell line the HD11
macrophages can survive and vigorously respond to simulated immune challenges without costimulation or exogenous survival factors. Even using targeted B cell and T cell antibodies and
compliment, lymphocyte removal peripheral blood samples is typically only 95% [23]. Semipure macrophage populations derived from peripheral monocytes thus may include a variety of T
cells and B cells which could more accurately mimic the in vivo response in vitro. As such in the
comparison of a homogenous, transformed cell population and a moderately heterogeneous, wild
type cell population, both are incomplete but potentially useful in describing the extremely
heterogeneous conditions in the chicken.

1.1.2 Macrophage Activation
Macrophages and monocytes can be activated through a variety of signals and receptor
binding ligands. Among these receptors, Toll-like receptor 4 (TLR-4) recognizes
lipopolysaccharide (LPS) constitutively found in gram-negative cell walls [35, 36]. Activating
macrophages with LPS requires a complex of TLR-4 with CD-14 and MD-2 [35]. LPS-bindingprotein (LBP) with bound LPS can also activate macrophages by binding CD-14 [35, 36]. TLR-2
4

in heterodimers with TLR-1 or TLR-6 can bind a variety of ligands including peptidoglycan,
bacterial lipoproteins, lipoarabinomannan and zymosan [29]. In addition TLR-5 binds bacterial
flagellin [29]. Intracellular pathogens are detected by TLR-3, TLR-7 and TLR-9 which respond
to double stranded RNA, single stranded RNA and CpG DNA in turn [29, 37]. In association
with their co-ligands these receptors can each initiate an immune response directed either at
intracellular or extracellular pathogens. Macrophages also express a variety of Fc receptors and
thus can target antibody-antigen complexes for phagocytosis [8, 12].
Once a macrophage is activated with LPS, this signal is propagated using MyD88 and the
serine/threonine kinase IL-1 receptor activated kinase (IRAK) to ultimately activate the
transcription factor nuclear factor κB (NFκB) [28, 37-40]. The increase in available NFκB results
in a pro-inflammatory immune response with increased transcription of inducible nitric oxide
synthase (NOS2 or iNOS) and IL-1β, IL-6, IL-8, IL-12 and TNF-α production [40-43]. Similar
macrophage activation can be achieved using TNF-α alone or in combination with LPS [10, 43,
44]. These cytokines enhance immune function, induce acute phase protein synthesis, serve as
chemoattractants for neutrophils, direct a TH1 type response and aid in extravasation to improve
immune cell exfiltration [6, 13, 36].

1.1.3 Macrophage Functions
Once activated, macrophages actively phagocytose and destroy bacteria utilizing a
respiratory burst mechanism [10, 15, 45]. The respiratory burst produces bactericidal compounds
known as the reactive oxygen species (ROS) and reactive nitrogen species (RNS). The RNS and
ROS produced include hydrogen peroxide, superoxide anion, peroxynitrite and nitric oxide (NO)
5

[46, 47]. All of these compounds are capable of causing oxidative damage to kill invading
microorganisms [48, 49]. Even in a culture devoid of immune cells, NO is capable of killing
Leishmania major [50]. NO contributes to anti-viral immunity by interfering with replication of
DNA and protein synthesis [21]. In conjunction with H2O2, NO causes double stranded DNA
cleavage, depletion of the antioxidant glutathione and increased death in E. coli [51]. The stable
byproducts of NO, nitrate and nitrite, are also bacteriostatic [46, 48].
NO has other biological uses and can be synthesized by neuronal nitric oxide synthase
(nNOS or NOS1) or endothelial nitric oxide synthase (eNOS or NOS3) which are both
constitutive Ca2+ dependent isoforms [52, 53]. These constitutive forms synthesize NO for
neurotransmission (nNOS) or vasoregulation (eNOS) [53]. The isoform utilized by macrophages
to synthesize NO, iNOS is Ca2+ insensitive and associates with the Ca2+ binding protein,
Calmodulin (CaM) in Ca2+ free media [21, 54]. Macrophages do however undergo rapid
oscillations in intracellular Ca2+ concentration upon activation and this may provide the minimal
amount required to saturate CaM [55]. Sustained production of NO is reliant on intracellular Larginine (ARG), NADPH and oxygen. D-arginine cannot be utilized for NO production, but
neither does it inhibit NO synthesis [21, 31, 56]. The reaction also requires flavin adenine
dinucleotide (FAD), flavin mononucleotide (FMN), tetrahydrobiopterin (BH4), and heme as cofactors [57, 58]. The active NOS enzyme regardless of isoform is a tetramer of two NOS
monomers associating with two CaM monomers [57]. Constitutive nNOS requires 200-300 nM
free Ca2+ to bind CaM and achieve half-maximal NO production [59, 60]. In mice, the CaMbinding region is the sequence residue 501-532 and is responsible for Ca2+ independent
activation of iNOS [60]. Regardless of isoform, the terminal amino group of ARG is cleaved to
produce NO and its co-product l-citrulline (CIT) [56]. Negative feedback from NO production
6

can occur through the production of stable nitrosyl species. This weakly inhibits iNOS, but has
been shown to inactivate as much as 90% of active nNOS [61].
Once pathogens have been destroyed in the phagolysosome by the respiratory burst, they
are processed for antigen presentation to by the endocytic pathway. The endocytic pathway
processes antigens for presentation on major histocompatibility complex type II (MHC II) [11].
Antigen loaded on MHC II is presented to TH cells, which are recruited to augment the innate
immune response [8, 11]. The process of antigen presentation and recognition is crucial for
pathogen clearance and the required for the development of immunological memory [8].
Macrophage cytokine production is important for immune clearance by activating a proinflammatory environment and recruiting adaptive immune cells [10]. Macrophages induce TH
cells into a TH1 type response with the production of IL-12 and IL-18, a response which results
in the TH1 cells producing macrophage augmenting cytokines[10, 62]. The cytokines IL-1β and
IL-6 assist in T cell activation and can induce fever [40, 63]. TNF-α further increases
inflammation and can trigger apoptosis in damaged and/or tumor cells through its receptor [13,
40]. With the assistance of TH1 produced cytokines, notably IFN-γ and the resulting increase in
MHC I or human leukocyte antigen (HLA) expression, activated macrophages have improved
tumor cell recognition and destruction capacity [20, 64].
Once pathogen clearance has been achieved, macrophages are involved in the subsequent
healing of the wounded environment [18, 19]. The enzyme arginase reduces the available
substrate for NO synthesis and retards the inflammation [56]. In the mouse macrophage,
Salmonella has been shown to up-regulate this pathway to survive inside phagocytic
compartments [15]. In addition to pathogen clearance, damaged or dead cells are induced to
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undergo apoptosis or are scavenged by macrophages [20]. Furthermore, cytokine production
recruits additional cells to the wound and improves angiogenesis [18]. The inhibition of
macrophages to limit collateral tissue damage and down-regulate activity post-pathogen
clearance relies on TH2 cytokines TGF-β and IL-10 [18, 27].
1.2 Nutrition and the Immune Response
Nutrition, metabolism and the immune response are interdependent and intermodulatory.
For example, exposure to LPS induces a febrile response through the production of proinflammatory cytokines and reduces nutrient intake [65, 66]. This innate response also modulates
nutrient availability on a tissue level by decreases amino acid uptake in skeletal muscle while
increasing it in the liver and leukocytes [2]. The extensively studied metabolic hormone insulin
regulates energy metabolism and promotes glucose uptake and utilization. Insulin also acts on
immune cells such as lymphocytes which preferentially utilize glucose as an energy source [67].
Nutritional status, such as starvation, can result in impaired T lymphocyte function in response to
low levels of leptin [68]. Leptin is also a regulatory hormone involved in food intake, basal
metabolism and energy expenditure [67, 68].
Nutrition can also modulate immunity and metabolism [69]. Nutrient modulation occurs
through numerous mechanisms including increased substrate supply for immune cells (amino
acids, Mg, Zn) or pathogens (Fe), protection from immunopathology (Vitamin E, Se,
carotenoids), altering signal transduction in immune cells (Vitamins A, D, E), altering gut
microbial populations (fiber) and hormonal balance [1, 2, 69, 70].
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1.2.1 Arginine Utilization
ARG, as a nutritional substrate for the immune system, has a role in immunomodulation
[69]. Depletion of circulating ARG has been shown in abdominal sepsis, trauma, post-surgically
and in cancer models [71]. Conversely, supplementation with dietary ARG improves wound
healing and improved survival versus tumors in mammals [18, 67, 71]. In addition to utilization
by macrophages, ARG is required for T cell proliferation, expression of the T cell receptor
complex and the development of memory T cells [71]. In the absence of ARG, CD4+ T cells
exhibit decreased CD3δ chain expression, but this effect is reversible by ARG supplementation
[72]. This decrease in CD3δ can be replicated by depleting ARG with arginase I, but not arginase
II or iNOS [72]. Increased lymphoid organ weights have also been observed in response to
higher dietary levels of ARG in chickens [69]. Additionally high dietary ARG improves T cell
proliferation and increases circulating monocyte percentages in growing broiler chicks [73].
Mature B cell proliferation and antibody production is not adversely affected by ARG
deprivation or early supplementation [74]. In mice, ARG deprivation during development results
in lower B cell numbers in the spleen and lymph nodes [75]. The implications of high dietary
ARG in chickens in production may be confounded by differences in production and
experimental facilities [69].
1.2.2 Arginine Metabolism
ARG is an essential, or conditionally essential, cationic amino acid depending on species
differences in ARG metabolism [56, 76, 77]. These differences correlate with ureotelic and
uricotelic nitrogen excretion strategies. ARG is processed through two major metabolic cycles
and is a precursor for many other products, the urea cycle and the Citrulline-NO cycle (Figure 1)
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[56]. It is also used for protein synthesis and is a precursor of NO, CIT, urea, ornithine,
polyamines, proline, glutamate and agmatine [56]. In aves and other uricotelic species, ARG is a
dietarily essential amino acid because they lack the complete array of urea cycle enzymes [76].
The complete urea cycle consists of five enzymes: arginase, carbamoylphosphotate
synthetase I (CPS I), ornithine transcarbamoylase (OTC), argininosuccinate synthetase (ASS)
and argininosuccinate lysase (ASL) [56]. Chickens lack mitochondrial CPS I and have low ASL,
ASS and OTC activity [76]. In mammalian, or ureotelic, species the complete urea cycle is
present and allows for ARG recycling [56, 77]. In young, growing animals ARG recycling is
insufficient to meet metabolic needs and it is dietarily essential [77]. Mature, healthy adults can
meet their ARG requirement without supplementation [56]. While ARG synthesis occurs in the
liver and kidney, the co-localization of urea cycle enzymes in the liver results in hepatic ARG
being utilized for urea synthesis [56, 77]. As such, in ureotelic species most de novo synthesized
plasma ARG is of renal origin. ARG is thus conditionally essential in ureotelic organisms based
on growth, age and health status.
The Citrulline-NO cycle consists of only three enzymes, NOS, ASS and ASL. This can
occur, albeit inefficiently, in most NO producing cell types independent of the active NOS
isoform [77]. As such, CIT supplementation in uricotelic and ureotelic animals is unable to
support high levels of NO synthesis in culture, but chickens can meet their ARG requirements by
dietary supplementation [76, 78]. Mammals however, can supply their ARG requirements from
ARG, CIT or ornithine supplementation [77]. Despite possessing the necessary enzymes,
mammalian macrophages are unable to utilize CIT for NO synthesis [79, 80].
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Figure 1. Overview of the Urea and Citrulline-NO cycles. The chicken lacks a complete urea
cycles because they lack carbamoylphosphate synthase I and have low activity of ornithine
transcarbamoylase (*), but these enzymes are present in ureotelic mammals. Abbreviations:
ASL, argininosuccinate lysase; ASS, argininosuccinate synthetase; L-Arg. Succ., Largininosuccinate; CPS I, carbamoylphosphate synthase I; Carbamoyl P., carbamoyl phosphate;
OTC, ornithine transcarbamoylase. Adapted from Sung et al 1991 [31].
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1.3 Arginine Transport
Immune cells and tissues, like other tissues, have different nutrient demands and
priorities during different physiological states [2]. Macrophages, for example, are a high nutrient
priority cell type within the immune system followed by B cells and T cells in decreasing priority
[81]. It follows that sepsis and wound healing are nutritionally demanding physiological states
[19]. These nutrients are obtained and prioritized by groups of nutrient transporters derived from
the solute carrier (SLC) superfamily of genes. Transporters are further divided based on
substrate, with three families capable of encoding ARG transporters: the system y+ cationic
amino acid transporters (CAT; SLC7A), systems y+L and b0,+ glycoprotein-associated amino
acid transporters (gpaAT; SLC7A and SLC3A) and system B0,+ the Na+/Cl- dependent
transporter (ATB0,+; SLC6A) [19]. As a cationic amino acid (CAA), ARG shares these transport
systems with other CAAs such as lysine and ornithine [56, 82].
1.3.1 System y+
System y+ consists of the glycosylated transmembrane transporters CAT1-4 with 12-14
transmembrane domains and cytosolic N and C-termini (Table 1) [19, 82-84]. CAT-2 is
alternatively spliced into CAT-2A and CAT-2B in mammals and also into the truncated CAT-2C
isoform in chickens [82, 85, 86]. CAT-4 exhibits approximately 40% homology to the other
CATs and has been identified as a CAT in plants, but its function in mammals and aves is not
clearly understood [86, 87].
The predominant transporter of the y+ system in mammals is CAT-1, a high affinity
transporter with a Km range of 0.10-0.16 mM [19, 88]. It is constitutively expressed in most cell
types with the notable exception of hepatocytes in adult mammals. Its expression can be
12

modified by cell proliferation, cytokines, hormones and nutrients [56, 88, 89]. In nutrient replete
conditions CAT-1 expression is low, but amino acid deprivation upregulates CAT-1 mRNA [88].
CAT-1 is vital to post-natal growth and development, knockout mice lacking the gene are runts
(~25% smaller) and die within 12h of birth [90]. Functional CAT-1 knockout models have been
developed using embryonic fibroblasts and while fetal development is impaired, embryonic cells
are still viable [90, 91]. In contrast, CAT-2 knockout mice are viable and fertile [45, 92]. CAT2A is a low affinity transporter with a reported Km of 2-5 mM and is found in the primarily in the
liver and skeletal muscle [19, 45, 83]. The alternative CAT-2 splicing produces a high affinity
isoform, CAT-2B with a Km similar to CAT-1 and CAT-3 [19, 82, 85, 86]. The expression of
CAT-2B in mammals is required for NO production in response to LPS or cytokine stimulation
in macrophages, but not in fibroblasts [45, 92]. In other cell types, an absence of CAT-2B can
impair NO synthesis to differing degrees [93, 94]. CAT-2B and iNOS are co-induced in
mammalian macrophages and CAT-2B preferentially transports ARG utilized by iNOS [45, 89].
The substrate affinity difference in the CAT-2 isoforms is determined by a 41 amino acid
sequence in the fourth intracellular region of the protein [19, 83, 86]. The chicken CAT-2B has a
crucial amino acid substitution when compared with the mammalian transporter. At the substrate
affinity conferring site, residue 369, a glutamine is replaced with lysine [85]. CAT-3 is also a
high affinity transporter and is found in the brain and thymus [19, 56, 84, 86]. In CAT-1
deficient models, such as fibroblasts, CAT-3 can functionally restore ARG transport for NO
synthesis [91].
Like mammals, chickens express different CAT isoforms depending on the tissue,
however the tissue distributions sometimes differs from their mammalian counterparts. CAT-1 is
not as ubiquitously expressed as it is in mammals and is found in the liver, skeletal muscle and
13

bursa but not in the heart, spleen or thymus [17]. CAT-2 is expressed in the liver, skeletal
muscle, bursa, heart, spleen and thymus [17]. Like mammals, chickens also splice CAT-2 into
multiple transporters, but they produce three variants: CAT-2A, CAT-2B and CAT-2C [85].
However, unlike mammals, CAT-2B is incapable of ARG transport and CAT-2C is a nonfunctional truncated protein [85]. CAT-3 is expressed in some skeletal muscle (pectoralis) but
not in others (gastrocnemius). It is also expressed in the bursa, heart, spleen and thymus, but not
in the liver [17]. The expression of the various chicken CATs also depends on physiological
conditions including stage of development, health status and nutrient availability. For example,
no isoform of CAT mRNA was detectable in the thymus or spleen until day 7 post hatch [17].
An immune challenge with LPS has no effect on CATs in the thymus, but increased CAT mRNA
in the liver and bursa [81]. Peripheral blood mononuclear cells responded to surplus dietary ARG
with increased expression of CAT-1 [73].
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Table 1. Description of y+ system transporters
Gene

CAT-1

CAT-2A

CAT-2B

Tissue
Distribution in
mammals
Ubiquitous,
excluding liver
Throughout
the body,
highest in liver
Immune cells

CAT-2C
CAT-3

n/a
Brain and
placenta

CAT-4

Placenta

Tissue
Distribution in
chickens
Liver, skeletal
muscle and
bursa
Ubiquitous

Approximate
ARG Km in
mammals
100-150 uM

Approximate
ARG Km in
chickens
Unknown

Sequence
Homology2

2-5 mM

6.5 mM

78-81%

Bursa, heart,
liver and
thymus
Ubiquitous
Pectoralis,
bursa, heart,
spleen and
thymus
Unknown

70-400 uM

NF

83-85%

n/a
40-165 uM

NF
Unknown

n/a
79-83%

Unknown

Unknown

n/a

1

94-96%

Abbreviations: ARG, L-arginine; n/a, not applicable; NF, non-functions
2
Sequence homology range compared to human, mouse and rat nucleotide sequences with BLAST
(http://blast.ncbi.nlm.nih.gov/)
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1.3.2 Systems y+L and b0,+
The systems y+L and b0,+ include the unglycosylated transmembrane proteins y+LAT1/2
and b0,+AT. These transporters form obligate heterodimers with the glycoproteins 4F2hc or
rBAT [82, 95]. While y+LAT1/2 primarily associates with 4F2hc and b0,+AT with rBAT,
overexpression of either 4F2hc or rBAT can produce different pairings [95]. Both transport
systems are high affinity obligate exchangers that exchange neutral amino acids for cationic
amino acids, [82, 95]. Both y+LAT-1 and b0,+ are most abundantly expressed in the small
intestine and kidney and indicate a role in amino acid absorption or reabsorption [19, 82, 95].
The transporter y+LAT-2, much like CAT-1, is ubiquitously expressed in mammalian tissues [19,
82, 95].
1.3.3 System B0,+
System B0,+ includes the Na+ and Cl- dependent transporter ATB0,+, a high affinity
glycosylated transmembrane transporter [19]. In addition to transporting CAAs ATB0,+ is capable
of transporting neutral amino acids with an apparent Km of 0.10-0.15 mM [19]. ATB0,+ is also
the only Na+ dependent ARG transporter. In part due to its broad transport capacity, ATB0,+ has
been a target for transmembrane drug delivery [96]. It has been shown in a wide variety of
tissues including the mammary gland, pituitary gland, stomach, colon, and eye, but is most
abundant in lungs and salivary glands [17, 19, 96].
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CHAPTER 2
Nitric oxide synthesis by chicken macrophages results in coordinated changes of multiple
arginine transporters
Introduction
Macrophages are vital to pathogen clearance, tumor suppression and wound healing [13]. They act through phagocytosis, cytokine production, production of toxic molecules and
antigen presentation cells [2-4]. They exist as quiescent monocytes in peripheral blood until
induced to extravasate and mature into macrophages [5]. Macrophages derived from peripheral
blood monocytes exhibit phagocytic behavior, cytokine production, nitric oxide production and
major histocompatibility II expression [6, 7]. Macrophage activation can occur through localized
tissue damage, stimulation of pattern recognition receptors (PRRs) or chemokine signaling [2, 8].
Commonly, lipopolysaccharide (LPS) or IFN-γ is used to simulate pathogen recognition in
macrophages by stimulating either Toll-like receptor 4 (TLR-4) or the IFN-γ receptor [1, 3, 8, 9].
Once activated, macrophages produce bacterially toxic compounds including nitric oxide
(NO), the superoxide anion (O2-), hydrogen peroxide (H2O2), the hydroxyl radical (OH-) and
hypochlorite (OCl-) [3, 10]. These compounds are produced inside endocytic vacuoles and
destroy engulfed bacteria using enzymes such as inducible nitric oxide synthase (iNOS or
NOS2), NADPH oxidase, superoxide dismutase and other peroxidase enzymes [10, 11]. This
process is known as respiratory, or oxidative, burst due to the increase in oxygen consumption to
produce microbicidal compounds. While NO production also requires oxygen, it is highly
dependent on the presence of the catabolic substrate L-arginine (ARG) [9]. ARG is first oxidized
to N-hydroxy-L-arginine, then to L-citrulline (CIT) and NO [12, 13]. The other metabolic fate of
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ARG is catabolism by arginase to L-ornithine and urea [12, 14]. This reduces the ARG available
for NO synthesis and can be utilized by bacterial species (e.g. Salmonella) to avoid destruction
[14, 15].
Ureotelic animals, such as mammals, can recycle CIT or L-ornithine in the kidney to
produce ARG and it is thus considered a conditionally essential amino acid [12]. While ARG
synthesis from CIT has been shown in mouse macrophages, rat alveolar macrophages and
chicken macrophages are unable to produce significant quantities of NO in low ARG, high CIT
media [16-18]. Thus the capacity for ARG synthesis is not biologically relevant for NO
production despite the presence of the requisite enzymes. Uricotelic animals lack carbamoyl
phosphate synthase I and ornithine transcarbamoylase and cannot synthesize the metabolic
precursors of ARG [19]. Thus in aves, ARG is an essential cationic amino acid because it cannot
be synthesized de novo. Avian macrophages are thus limited to ARG acquired in the diet for NO
synthesis [9].
In mammals, ARG is imported into the macrophage by the cationic amino acid
transporter 2B (CAT-2B) [20]. CAT-2B and iNOS mRNA transcription are co-induced in
response to cytokine activation or TLR-ligand binding [20, 21]. Mouse macrophages lacking
CAT-2B import 95% less ARG and produce 92% less NO [20]. The chicken CAT-2 gene is
alternatively spliced to produce three isoforms (CAT-2A, CAT-2B and CAT-2C). Chicken CAT2A isoform is a high velocity, low affinity transporter that is predominantly expressed in the liver
and skeletal muscle [22, 23]. Chicken CAT-2B is the isoform homologous to mammalian CAT2B; however, chicken CAT-2B does not transport LYS or ARG [22]. This difference has been
attributed to a substitution of Lys369 for Glu369 in the affinity-conferring region of the transporter.
The chicken CAT-2C isoform results in a non-functional, truncated protein [22].
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The other ARG capable transporters present in mammals and aves are CAT-1 and CAT3., CAT-1 and CAT-3 are high affinity transporters and have variable tissue distributions
depending on species [23]. Chicken CAT-1 mRNA is found in the bursa, thymus, skeletal
muscle and liver, but not in the heart or spleen [24]. In mammals, CAT-1 is found in nearly all
tissues except hepatocytes [25]. Chicken CAT-3 has a slightly lower affinity than CAT-1 and is
found in the bursa, thymus, heart and pectoralis [24]. The mammalian CAT-3 is expressed in the
thymus, brain, uterus and testis [25]. With CAT-2B not importing ARG for chicken macrophage
NO production, another transporter(s) must allow for ARG import. These broad differences in
species CAT expression do not indicate a likely candidate for ARG import for NO production in
aves.
Due to the absence of a functional homologue to mammalian CAT-2B in the chicken
macrophage, CAT-1, CAT-2A and CAT-3 were investigated for their role in ARG transport.
Experiments were performed to: 1) identify the changes in ARG transporter mRNA abundance
due to activation in primary and immortalized macrophages; 2) determine the effect of
transiently over-expressing ARG transporters on NO production.
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Materials and Methods
2.1 Cell Culture
HD11 cells obtained courtesy of Dr. Mike Kogut (Southern Plains Agricultural Research
Center, TX) were cultured in T75 flasks (Corning, Corning, NY; 430720) in complete medium
(IMDM without phenol red [Invitrogen, Carlsbad, CA; 12440], 5% fetal bovine serum
[Invitrogen, Carlsbad, CA; 16000], 2% penicillin/streptomycin [Invitrogen, Carlsbad, CA;
15140] and 1% L-glutamine [Sigma, St. Louis, MO; G7513]) at 37 C with 5% CO2.

2.2 Experimental Design
2.2.1 Experiment 1: Determining Experimental Conditions
HD11 cells for nitric oxide analysis were cultured in 96-well plates (Fisher, Pittsburg,
PA; 353070) at 2x105 cells/well (n=4/time point) in 200 µL complete media containing 0, 0.1, 1
or 10 µg/mL Escherichia coli lipopolysaccharide (LPS; Sigma-Aldrich, St. Louis, MO; L4005).
Media was collected at 24, 48 and 72 h for nitric oxide analysis. HD11 cells for multiple time
point nitric oxide analysis were cultured in 96-well plates at 4x105 cells/well (n=3) in 300 µL of
complete media containing 0 or 1 µg/mL LPS. Media (50 µL) was collected from either the same
or different set of wells at 6, 18, 24, 36 and 48 h. Nitric oxide concentration from repeatedly
sampled wells was corrected for the effect of reducing well volume with the following equation:

–

yi =
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where yi = corrected nitrite concentration of sample i; xi = raw nitrite concentration of sample i;
xi-1 = x0 = 0 µM nitrite; Vi0 = Initial volume in µL; n = media volume sampled per time point in
µL [26].

2.2.2 Experiment 2: Transporter Identification during a NO Response
HD11 cells were cultured in 6-well plates (Fisher, Pittsburg, PA; 353046) at 4x105
cells/well (n=6) in complete media containing 0 or 1 µg/mL LPS. Media (500 µl) was collected
at 24 and 48 h for nitric oxide analysis and cells were detached using cell scrapers (Fisher,
Pittsburg, PA; 353085). Cells were centrifuged for 5 min at 500 x g at 25°C. The media was
aspirated and cell pellets were flash frozen in liquid nitrogen and stored at -80°C.
Peripheral blood was collected from Cobb 500 broilers (n=8) and Hyline W36 layers
(n=7) by cardiac puncture into heparinized tubes for isolation of macrophages. Cells were
analyzed for viability and the macrophage marker KUL01 by flow cytometry. Macrophages were
plated in 6-well plates at 4x105 cells/well in complete media containing 0 or 1 µg/mL LPS.
Media (500 µl) was collected at 24, 48 and 72 h for nitric oxide analysis. Macrophages were
collected at 72 h in RPMI-1640 (Invitrogen, Carlsbad, CA; 11879-020) using cell scrapers and
were centrifuged for 5 min at 500 x g at 25°C. The media was aspirated and cell pellets were
flash frozen in liquid nitrogen and stored at -80°C.
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2.2.3 Experiment 3: Over-expression of CATs by Transient Transfection
Transfected HD11 cells were plated in 96-well plates at 4x105 cells/well in 300 µL
IMDM complete media containing 0 or 1 µg/mL LPS. Supernatant (50 µL) was collected at 6,
12, 24, 36 and 48 h. The remaining media was aspirated and the cells were detached with typsin
(8.0g Sodium chloride [Fisher, Pittsburg, PA; S671], 0.4g potassium chloride [Fisher, Pittsburg,
PA; P217], 1.0g glucose [Sigma-Aldrich, St. Louis, MO; G8270], 0.35g sodium bicarbonate
[Fisher, Pittsburg, PA; S233], 0.5g Trypsin [Sigma-Aldrich, St. Louis, MO; T-4799], 0.2g
EDTA [Sigma-Aldrich, St. Louis, MO; E8145], 0.06g potassium phosphate monobasic [Fisher,
Pittsburg, PA; P285], 0.09g sodium phosphate dibasic [Fisher, Pittsburg, PA; S381] in 1L
ddH20] for 10 min at 37°C with 5% CO2 and were quenched with complete media. Cells were
analyzed by flow cytometry for viability and transfection efficiency.

2.3 Macrophage isolation
In experiment 2, macrophages were isolated from male 32d old Cobb 500 broilers (n=8)
or actively laying Hyline W36 (n=7). Broilers and layers were provided access to water and a
standard commercial ration ad libitum. Whole blood was collected into heparinized (Hospirin,
Inc., Lake Forrest IL; 0409-1402-31) syringes via cardiac puncture and stored on ice.
Heparinized blood was overlaid onto isovolumetric Histopaque-1077 (Sigma-Aldrich, St. Louis,
MO; #10771) and centrifuged for 15 min at 350 x g at 25°C to obtain peripheral blood
mononuclear cells. The buffy coat was reconstituted in RPMI-1640 (Invitrogen, Carlsbad, CA;
22400) and centrifuged for 5 min at 500 x g at 25°C. Cell pellets were resuspended in RPMI1640 complete media (RPMI-1640 containing 5% fetal bovine serum, 2%
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penicillin/streptomycin and 1% l-glutamine). The cells were then plated (cells from 1 bird/plate)
in 10 cm2 plates (Fisher, Pittsburg, PA; 353003) overnight at 37 C with 5% CO2. After an
overnight adherence, media was aspirated and the plates were washed twice with RPMI-1640 to
remove heterophils and erythrocytes. The cells were then collected in RPMI-1640 complete
media using cell scrapers and enumerated via hemocytometer.

2.4 Nitric oxide assay
Nitric oxide (NO) was measured in media samples collected from experiments 1-3 using
the Griess Reagent System (Promega, Madison, WI; G2930) for optical density at 550 nm.
Standard curves were run in triplicate to produce the predictive equation (R2 >0.99) used to
calculate sample concentrations. Sample concentrations containing less than 2.5 µM nitrite were
considered to be below the detection limit of the assay.

2.5 Total RNA Isolation
Total RNA was isolated from cell pellets collected in experiment 2 using NucleoSpin
Extract II kits (Macherey-Nagel, Bethlehem, PA; 740955) per the manufacturers protocol. Total
RNA was quantified at optical density 260 nm and 1 µg total RNA per sample was reverse
transcribed using the iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA; 170-8891) according
to the manufacturers’ protocol.
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2.6 Quantitative Real-Time PCR
Quantitative real-time PCR was performed on a 7500 Fast Real-Time PCR System
(Applied Biosystems, Foster City, CA) using Fast SYBR Green Master Mix (Applied
Biosystems, Foster City, CA; 4385610), 1 μL of reverse transcription cDNA product, and 10
μmol/L of each primer (Table 1). Thermal cycling parameters were 1 cycle of enzyme activation
at 95°C for 20 s and 40 cycles of denaturing at 95°C for 3 s and annealing and extending at 60°C
for 30 s. After 40 cycles, melting curve analysis was performed at 95°C for 15 s, 60°C for 60 s,
followed by a linear temperature increase of 0.5°C/s to 95°C while continuously monitoring
fluorescence. Samples containing primer dimers were considered below the level of detection
and were excluded from analysis. Relative mRNA abundance was calculated using the modified
Δ-Δ equation as previously described [27]. Amplification efficiency was determined with
LinRegPCR during the log-linear phase of amplification [28]. Normalization of target mRNA
genes was performed by geometric averaging of non-normalized β-2 microglobulin,
glyceraldehyde 3-phosphate dehydrogenase and hypoxanthine-guanine
phosphoribosyltransferase using GeNorm software [29]. Data are represented as normalized fold
abundance relative to 0 µg/mL LPS for each transporter. Since CAT-1 and HD11 CAT-3 mRNA
was below the limit of detection in the 0 µg/mL LPS treatment data were normalized to y+LAT1.

2.7 Transient Transfection
HD11 cells were transiently transfected with expression vectors containing chicken CAT1, CAT-2A and/or CAT-3 using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA; 11668019). The open reading frame (ORF) for chicken CAT-1, CAT-2A and CAT-3 were amplified
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using Platinum Taq DNA polymerase and were cloned in-frame into pcDNA5/FRT/V5-HISTOPO mammalian expression vector (Invitrogen, Carlsbad, CA). The forward primer contained
a kozak sequence and the stop codon on the reverse primer was deleted to allow for expression
of a C-terminal V5 epitope. A control plasmid provided with the kit contained chloramphenicol
acetyltransferase in the pcDNA5/FRT/V5-HIS-TOPO vector was used as an over-expression
control. Lipofectamine (0.2 µg/well) was diluted in Opti-Mem (Invitrogen, Carlsbad, CA;
31985) and allowed to conjugate with 0.2 µg plasmid/well in Opti-Mem for 20 min at 25°C.
Conjugated plasmids were then added to IMDM incomplete media (no pen/strep) containing
4x105 cells/well and incubated for 4 h at 37C with 5% CO2.

2.8 Flow Cytometry
Primary macrophage and transfected cell viability were analyzed using the EasyCyte Plus
System (Millipore, Danvers, MA) with a 488 nm argon laser with ViaCount Reagent (Millipore,
Danvers, MA; 4000) per the manufacturer’s instructions. Primary cell isolates were analyzed
using mouse monoclonal R-phycoerythrin (R-PE) conjugated antibody (Southern Biotech,
Birmingham, AL; 8420-09) KUL01 specific for monocytes and macrophages. Transfection
efficiency was analyzed using mouse monoclonal fluorescein isothiocyanate (FITC)-conjugated
antibody (Invitrogen Carlsbad, CA; R963-25) specific for the V5 epitope. Cells were washed
with DPBS (Invitrogen, Carlsbad, CA; 14040) and permeabilized with 0.2% Triton X-100
(Integra Chemical Company, Kent, WA; T756.30.30) for 10 min. Cells were washed twice with
DPBS and blocked with SuperBlock Blocking Buffer (Fisher, Pittsburg, PA; 37515) for 20 min.
Excess blocker was removed with two DPBS rinses. Blocked samples were stained with 0.238
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µg/mL anti-V5-FITC in DPBS for 1 h at 25°C protected from light. Cells were washed once with
DPBS, detached by trypsin addition for 5 min at 37, and quenched with complete media without
phenol red. Cells were then analyzed for FITC or R-PE fluorescence using Guava CytoSoft
Software (Millipore, Danvers, MA) on EasyCyte Plus System.

2.9 Statistics
Dependent variables were analyzed by the general linear model (MiniTab Software,
Minitab Inc. State College, PA) using either a one-way or two-way analysis of variance
(ANOVA). The effect of LPS treatment on HD11 NO production, NO dose response and ARG
transporter mRNA abundance were analyzed with a one-way ANOVA. Transfected HD11 NO
and monocyte NO assays were analyzed by two-way ANOVA to determine the main effect of
LPS treatment, sample origin, and their interaction. Differences were considered significant
when P<0.05, and means were compared by student’s pair-wise comparison. Transfection
efficiency and viability data were arcsin transformed to meet the conditions for ANOVA. Data
are shown as untransformed means and pooled standard error.

39

Table 2. Primers for quantitative real-time PCRa
Gene
Primer Sequence
Amplicon Length (bp) Accession Number
CAT1
Sense
5’-ACCTCCATCGTCATCTCCTTC-3’
252
EU360441
Antisense
5’-AAGTCTTCAATGTGCCACCTATG-3’
CAT2A
Sense
5′-TGCTTTGTCTACAAGTCTTCTCG-3’
165
EU360448
Antisense
5’-AATGCCATAATACCAGAGATGACC-3’
CAT2B
Sense
5’-CTTTGCTTGTCTGCTTCATGG-3’
272
EU360449
Antisense
5’-CTTCGTTTTGGAATTGATTTGAGC-3’
CAT3
Sense
5′-CCACGGGCACCAAACAGAAG-3′
150
XM_420204
Antisense
5′-CAGTCAGCACCACGCAGATG-3′
y+LAT1
Sense
5′-GTTGGAGCCAGAGAAGGACATC-3′
165
XM_418326
Antisense
5′-AAGCCAGTAGTTGAAGCAGTAGTAG-3′
y+LAT2
Sense
5′-TTGTTCTCTTATTCTGGTTGGGATAC-3′
100
XM_001231336
Antisense
5′-TTGGCATAGACACAGCAATAGC-3′
NOS2
Sense
5’-GCTGTACTCTTTGCGTCATTACTC-3’
90
NM_204961.1
Antisense
5’-TGATTTCCCAGTCTCGGTTGC-3’
GAPDH
Sense
5’-GGTGCTGAGTATGTTGTGGAGTC-3’
290
NM_204305.1
Antisense
5’-GTCTTCTGTGTGGCTGTGATGG-3’
HPRT-1
Sense
5′-GCCAGACTTTGTTGGATTTGAAG-3′
213
NM_204848
Antisense
5′-AGAGTTGAAGCCTGTGAGAGATAG-3′
B2M
Sense
5′-TGGAGCACGAGACCCTGAAG-3′
161
XM_424099.2
Antisense
5′-TTTGCCGTCATACCCAGAAGTG-3′
a
Abbreviations: B2M = β -2 microglobulin; CAT = cationic amino acid transporter; GAPDH = glyceraldehyde 3-phosphate
dehydrogenase; HPRT-1 = hypoxanthine phosphoribosyltransferase-1; NOS2 = nitric oxide synthase 2 or inducible nitric oxide
synthase; y+L type amino acid transporter;
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Results
2.10 Experiment 1: Determining Experimental Conditions
2.10.1 Timeline and Dose Response
In order to evaluate the conditions for a maximal NO response in the HD11 cell line, a
timeline and dose response was performed. Surprisingly, the HD11 response to LPS showed no
significant time-dose interaction (P>0.05; data not shown) or effect of time (P>0.05; data not
shown). Maximal nitric oxide (NO) production occurred with 1 µg/mL LPS (Figure 1; P<0.05).
Subsequent experiments were performed with 1 µg/mL LPS.
2.10.2 Repeat Sampling Conditions
In order to determine if repeat sampling had a biological or merely volumetric effect on
NO production, repeat sampling was compared to single sampling and transformed repeat
sampling. The HD11s produced no detectable NO by 6 h, regardless of LPS treatment (data not
shown). At 18, 24 and 36 h there was no difference between NO concentrations between singlesampled, repeat-sampled wells and corrected repeat-sampled wells (Figure 2A-C; P>0.05). By 48
h, the repeat-sampled wells resulted in higher NO concentration compared to controls (Figure
2D; P<0.05), but corrected repeatedly-sampled and controls produced the same amount of NO
(P>0.05). As such repeat sampling had volumetric and not biological effects and subsequent
experiments utilizing repeat sampling were adjusted using the concentration correction formula.
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Figure 2. Nitric oxide production by HD11 cells (2x105 cells/well). Means not sharing a
common superscript (a-c) differ within a time point (P<0.05). Means did not differ between time
points (P>0.05). Values represent the mean  SEM (n=12).
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Figure 3. Nitric oxide production at 18h (A), 24h (B), 36h (C), and 48h (D) by HD11 cells
(4x105 cells/well) in response to LPS with or without repeated sampling and adjustment
algorithms. Means not sharing a common superscript differ (P<0.05). Values represent the mean
 SEM (n=4).
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2.11 Experiment 2: Transporter Identification during a NO Response
2.11.1 Nitric oxide response
Before quantifying the transporters involved in a NO response, the NO response was first
verified by quantifying NO and iNOS mRNA. In the HD11 cell line at 24 and 48 h (Figure 3AB), 1 µg/mL LPS increased NO concentrations above controls (P<0.05) and at 48 h LPS
increased iNOS mRNA abundance 8.5-fold (P<0.05) above controls (Table 2).
After verifying a NO response in the HD11 cell line, the NO response to LPS in primary
macrophages (Table 3) was evaluated by measuring NO and iNOS mRNA. The magnitude of
NO production in response to LPS differed between layer and broiler macrophages (Figure 4).
NO production by layer macrophages was greater than broiler macrophages at 24, 48 and 72 h
post-LPS (Figure 4A-C). The broiler macrophage NO response to LPS was similarly increased
over controls at all time points (P<0.05). In broiler and layer macrophages (Table 2), iNOS
mRNA abundance increased (P<0.05) 3.22-fold and 2.79-fold, respectively.
2.11.2 Transporter mRNA Abundance
Once a NO response to LPS had been shown in cell line and primary macrophages, ARG
capable transporters were quantified in all three cell types. Both CAT-1 and CAT-3 were
induced in HD11s in the presence of LPS (Table 2). The low-affinity importer CAT-2A
increased 1.68-fold (P<0.05) in response to LPS and CAT-2B mRNA was not detected in
treatments or controls. In the presence of LPS, y+LAT-1 decreased 69.5% (P<0.05) and y+LAT-2
mRNA abundance was unaltered (P=0.95).
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Broiler and layer macrophage CAT-1 mRNA was induced in response to LPS (Table 2).
The mRNA abundance of CAT-2A and CAT-3 showed a similar pattern of change in both
strains in response to LPS. CAT-2A mRNA increased 1.33-fold in broilers (P<0.05) and 1.28fold in layers (P<0.05) while CAT-3 mRNA increased 1.27-fold in broilers and 1.23-fold in
layers (P<0.05). y+LAT-1 did not change in either strain in response to LPS (P>0.05), but
y+LAT-2 increased (P<0.05) 2.35-fold in broilers and 2.24-fold in layers.
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Figure 4. HD11 (4x105 cells) nitric oxide production at 24 and 48 h. Asterisks represent
significant difference (P<0.05) within a time point. Values represent the mean  SEM (n=6).
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Figure 5. Nitric oxide production by macrophages from 32d old all male Cobb broiler chickens (A; n=8; 4x105 cells/well) and
actively laying White Leghorns (B; n=7; 4x105 cells/well). Means not sharing a common superscript (a-d) differ (P<0.05). ND
represents samples that were below the level of detection (<0.78 mM nitrite). Values represent the mean  SEM.
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Table 3. Relative mRNA abundance of arginine transporters and inducible nitric oxide synthase in
HD11 and primary macrophages from broilers and layers1

Relative mRNA
Cell Source
Abundance
P-value
HD11
Induced2
NA
2
Broiler
Induced
NA
2
Layer
Induced
NA
HD11
1.676±0.241
<0.05
CAT-2A
Broiler
1.327±0.058
<0.05
Layer
1.283±0.129
<0.05
2
HD11
Induced
NA
CAT-3
Broiler
1.265±0.063
<0.05
Layer
1.227±0.085
<0.05
+
HD11
.3049± 0.186
<0.05
y LAT-1
Broiler
1.052±0.164
0.387
Layer
1.023±0.304
0.856
+
HD11
1.034± 0.812
0.950
y LAT-2
Broiler
2.352±0.115
<0.05
Layer
2.242±0.267
<0.05
HD11
8.514± 0.159
<0.05
iNOS
Broiler
3.216±0.247
<0.05
Layer
2.794±0.168
<0.05
1
values represent fold mRNA abundance relative to 0µg/mL LPS; NA = not applicable; ND = not
detected; CAT = cationic amino acid transporter; y+L type amino acid transporter; iNOS2 = nitric oxide
synthase 2 or inducible nitric oxide synthase.
2
Indicates mRNA detected in 1µg/mL LPS and no detectable mRNA in 0 µg/mL LPS.
Gene
CAT-1
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Table 4. Primary cell isolate viability and KUL01 staining for verification of macrophage
phenotype from broilers and layers identified by flow cytometry1

Cell Source

Viable Cells2

KUL01 Positive Cells3

Cell Count

Broiler

934±32.8.

3052±118

1.49±0.13x106a

Layer

910±26.5

2572±135

2.43±0.16x106b

1

Means not sharing a common superscript differ (P<0.05). Values represent the mean±SEM (n=3)
Viable cells per 1000 events
3
KUL01 positive cells per 5000 events
2
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2.12 Experiment 3: Over-expression of CATs by Transient Transfection
2.12.1 High Affinity Transporter Transient Transfection
The initial transient transfection was performed using the two high affinity ARG
importers that were found to be induced or increased in response to LPS, CAT-1 and CAT-3.
Transient transfection was performed with CAT-1, CAT-3 or CAT-1/CAT-3 plasmids and
utilizing a non-plasmid mock transfection as a control. At 6 h post LPS treatment, no effect of
LPS treatment was seen (P>0.05), but all transfected cells showed an increase of 15-18 µM NO
compared to mock transfected controls (Figure 5A; P<0.05). After 12 h, mock transfected
controls produced NO in response to LPS at a lower concentration than all plasmid treatments
(P<0.05; Figure 5B). LPS increased NO production in CAT-1 transfected cells above transfected
cells treated with 0 µg/mL LPS and multiple plasmid transfected cells treated with LPS (P<0.05).
By 24 h, the CAT-1 with 1 µg/mL LPS combination produced the highest concentration of NO
(P<0.05) followed by mock transfected cells with 1µg/mL LPS. The mock transfection with LPS
produced more NO than non-LPS treated transiently transfected cells (P<0.05; Figure 5C). After
36 h, over-expressing CAT-1 in the presence of LPS produced the maximal response of 89.3 µM
NO (P<0.05; Figure 5D). In the absence of LPS, CAT-1 transfected cells produced the same
amount of NO as the transfection control treated with LPS at 48 h (P>0.05). Cells transfected
with CAT-3 produced the same amount of NO, independent of LPS or CAT-1 co-overexpression, and at a lower concentration than LPS positive controls.
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Figure 6. Nitric oxide production at 6h (A), 12h (B), 24h (C), and 36h (D) by HD11 cells (4x105
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mean  SEM (n=8).
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2.12.2 Evaluation of Controls for Transient Transfection
After observing the inhibitory response of CAT-3 plasmid in response to LPS compared
to mock transfected cells, further transfections were performed to evaluate mock transfection as a
control. A second transfection was performed using the mock transfection as one control and a
transient transfection with plasmid containing a non-transporter gene (chloramphenicolacetyltransferase) as a plasmid control. CAT-3 transfection was repeated here as a sample
experimental treatment shown to exhibit sub-maximal NO production.
After 6 h, no effect of LPS was observed (P<0.05), but all plasmid transfected cells
showed the same increased NO response over the non-plasmid controls (P<0.05; Figure 6A). The
non-plasmid control and CAT-3 treatment showed similar NO production in response to LPS at
12 hours (Figure 8B). The control plasmid transfected cells and non-LPS treated transfected cells
all produced similar amounts of NO (P>0.05). At 24 h, the non-plasmid control produced the
highest concentration of NO at 93.2 µM in response to LPS (P<0.05; Figure 6C). The cells overexpressing CAT-3 in the presence of LPS produced more NO (P<0.05) than the plasmid control
cells with LPS or non-LPS treated plasmid transfected cells, which all produced similar
quantities of NO (P>0.05). At 36 and 48 h, the non-plasmid transfected cells in the presence of
LPS produced the highest NO concentration (P<0.05) with over-expressed CAT-3 cells
producing the 2nd highest concentration in response to LPS (P<0.05; Figure 6D-E). From 36 h
onward CAT-3 transfected cells not treated with LPS produced more NO than the plasmid
control (P<0.05), which produced the same quantity of NO regardless of LPS treatment
(P>0.05).
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2.12.3 Transient Transfection
In order to evaluate effect of over-expression of the CATs and to account for the effect of
plasmid-LPS interaction, another transfection was performed. The transfection was performed
using both mock transfected and plasmid controls alongside CAT-1, CAT-2A, CAT-3 and CAT1/2A/3. After 6 h, no effect of LPS was observed (P>0.05), but CAT-1 and CAT-1/2A/3 plasmid
treatments produced higher concentrations of NO than other transiently transfected cells (Figure
7A). Over-expressing CAT-3 only resulted in moderate amounts of NO production while CAT2A alone produced the same amount of NO as the plasmid control at 6 h. At 12 h post LPS
incubation NO production was observed in mock transfection controls with LPS at higher
concentration than in either plasmid controls with LPS or CAT-2A over-expressed cells with
LPS (P<0.05; Figure 7B). From 12 to 48 h post LPS treatment, over-expressed CAT-1 with LPS
produced maximal NO (P<0.05; Figure 7B-E). Until 36 h post LPS treatment, the CAT-1/2A/3
treated cells produced more NO in response to LPS than mock transfected controls, but no
difference existed after 48 h (Figure 7E). In non-LPS treated cells, over-expression of CAT-1
produced the highest concentration of NO with CAT-1/2A/3 producing slightly lower amounts
between 24 and 48 h (P<0.05; Figure 7C-E). Mock transfected cells in the presence of LPS
equaled NO production from CAT-1/2A/3 without LPS by 24 h (P>0.05; Figure 7C), equaled
CAT-1 without LPS by 36 h (P>0.05; Figure 7D) and exceeded all non-LPS treated
combinations by 48 h (P<0.05; Figure 7E). Both CAT-2A and the plasmid control induced low
amounts of NO production in the absence of LPS at all time points, but in the presence of LPS
small increases in NO production were observed (P<0.05).
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2.12.4 Transfection Verification
After transfecting with dual controls and the full spectrum of CATs, transfected cells
were analyzed by flow cytometry to evaluate the potentially detrimental effect of lipofectamine
transfection and LPS. Transfected HD11 cell viability did not differ due to plasmid contents or
lack of plasmid (P=0.66) or LPS treatment (P=0.13), though a numerical decrease was observed
in treatments with increased quantities of plasmid (Table 4). The total number of cells recovered
did not differ by transfection treatment (P=0.81) or LPS (P=0.85).
The transfected cells were analyzed for successful transfection by V5-epitope staining.
The number of the successfully transfected cells producing V5-tagged proteins did not differ by
plasmid content (P>0.05) or LPS treatment (P=0.94) and mock transfection resulted in no
evidence of V5-positive transfection product (P<0.05).
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Table 4. Recovered viable, v5-positive stained and original cells per well from transiently
transfected HD11 cells identified by flow cytometry1

Mock Transfected
Plasmid Control
CAT-1
CAT-2A
CAT-3
CAT-1/2A/3

LPS
0 µg/mL
1 µg/mL
0 µg/mL
1 µg/mL
0 µg/mL
1 µg/mL
0 µg/mL
1 µg/mL
0 µg/mL
1 µg/mL
0 µg/mL
1 µg/mL

Viable Cells2
950±12.9
969±6.9
959±6.9
929±12.5
932±10.5
935±27.1
938±16.2
923±22.0
927±9.0
905±15.3
890±15.7
898±21.3

1

v5 Positive Cells3
18±2.8a
26±4.6a
1652±12.0b
1602±21.6b
1607±18.1b
1612±46.7b
1616±27.9b
1591±38.0b
1597±15.5b
1559±26.4b
1534±27.1b
1548±36.7b

Cells/well
3.34±0.15x105
3.34±0.25x105
3.36±0.78x105
3.23±0.16x105
3.22±0.14x105
3.27±0.26x105
3.17±0.85x105
3.26±0.24x105
3.190.11x105
3.16±0.13x105
3.03±0.18x105
3.17±0.23x105

Means not sharing a common superscript differ (P<0.05), Values represent the mean±SEM (n=4)
Viable cells per 1000 events
3
v5 positive cells per 5000 events
2
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Discussion
The transporters coordinating ARG uptake in the chicken macrophage for a NO mediated
immune response have not been fully elucidated. Previous studies indicate that the avian
mechanism differs from the mammalian system which relies on CAT-2B because the chicken
CAT-2B protein does not transport ARG [20, 22]. These experiments provide evidence that in
the absence of a CAT-2B based system, CAT-1 and CAT-3 both act in support of an oxidative
burst in the chicken macrophage.
In general chickens are relatively insensitive to LPS, a dose of 1 mg/kg may be required
to induce an inflammatory response whereas in humans dosages as low as 2-4 pg/kg can induce
an immune response [30]. In production animals, an immune response can be detrimental to
weight gain, feed intake and protein accretion, increasing the cost of production [31]. As a result,
chicken breeding in favor of production traits has led to animals which are relatively insensitive
to LPS [30]. The short generation cycle and human-centered selected is in contrast to humans,
where survival is the dominant pressure is survival. These differences in sensitivity and
inflammatory response correlate with critical differences in ARG utilization by macrophages of
uricotelic species, like chickens, and ureotelic species like mice and humans.
The ARG capable importers show a similar pattern of increase and induction in the
broiler and layer macrophage. These mRNA abundance similarities exist despite the confounding
effects of age and sex of the birds. This pattern indicates a conserved mechanism for obtaining
extracellular ARG for NO production. The high affinity ARG importer CAT-1 was induced in
primary macrophages and the immortalized HD-11 macrophage cell line. A second high affinity
ARG importer, CAT-3, was increased in primary macrophages and induced in cell line
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macrophages. While CAT-2A also increased, it is a low affinity ARG transporter and in
mammals is insufficient to increase constitutive NO production [22]. The absence of detectable
CAT-2B in these experiments support earlier work showing CAT-2B- not being involved in NO
production as it is in mammals [20, 22]. This makes the chicken macrophage a unique model
rendering mammalian-based predictions on ARG utilization for NO production tenuous at best.
CAT-1 and CAT-3 are capable of sustaining constitutive NO production when transiently
induced in cultured macrophages. Over-expressing CAT-1, but not CAT-3, during a LPSinduced respiratory burst produced maximal NO. However, CAT-3 has also been shown to
restore NO production in CAT-1 deficient cells [32]. CAT-2A over-expression increased NO by
34% in response to LPS at 48h, a marginal increase compared to CAT-1, a 1045% increase, or
CAT-3, a 450% increase. These data indicate that CAT-1 is the dominant ARG importer for NO
production in the chicken macrophage, but that CAT-3 is also sufficient for a NO response. The
capacity of these transporters to facilitate a NO response without an immunogen indicates that
the limiting factor in immortalized chicken macrophages is not iNOS but the availability of
catalytic substrate ARG.
The y+LAT system of exporters showed an inverse relationship with the magnitude of
NO produced in broiler and layer macrophages. Decreased levels of y+LAT-1 in the HD11
macrophage in response to LPS were observed in conditions that resulted in high levels of NO
production (~100µM). The converse was observed in macrophages from both broiler and layer
chickens where y+LAT-2 increased and maximal levels of NO were ~10-25% of the maximal
production observed in HD11s. The increase in y+LAT2 may enable ARG export as shown in
erythrocytes and fibroblasts but not in other tissues [33, 34]. This increase in y+LAT2 may be
preparing the cell to down-regulate the NO response after pathogen clearance. Despite the
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correlation between the y+LAT type exporter mRNA abundance and NO response, the effect of
increased ARG importers by transient transfection indicates importers and not exporters are
limiting for NO production. These magnitude differences concur with other studies showing that
transformed cell line macrophages are more responsive to LPS than primary macrophages of
varying genetic lineage [35].
The relative change in iNOS mRNA abundance showed a positive relationship with the
magnitude of the NO response. The enzyme iNOS is typically thought of as an inducible
enzyme. The presence of iNOS mRNA without stimulation and the NO response at 6h when the
cells were transfected with CAT containing plasmid indicates a constitutive presence of the
enzyme. Utilizing siRNA in the HD11 cell line, iNOS mRNA abundance can be reduced as
much as 50-fold, but the decrease in NO production ranges 14-28% at 48 h [36]. These data
indicate post-transcriptional control, such as substrate availability, in the respiratory burst
mechanism of chicken macrophages. The maximal NO concentrations observed were limited by
intracellular ARG availability, ARG uptake, or iNOS abundance rather than ARG in the culture
medium. ARG in the medium was present at a concentration approximately 4-fold more
abundant than the amount utilized and double the 200µM threshold at which increased ARG
increases NO production [16]. As such, the culture media ARG concentration was not a pertinent
factor in observed NO response to LPS.
While genetic similarities between production animals exist despite the confounding
factors of age and sex, the magnitude of their NO response was greater than 2-fold different by
72h. The sensitivity of aging individuals and sex-related differences occur across species [3740]. Senescent mice show higher sensitivity to LPS and have increased NO production mediated
by TNF-α [40]. Young mice are less sensitive than senescent animals, but more responsive to
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LPS than mature mice [40]. While TNF-α was not investigated in this study, the LPS sensitivity
and NO production trend would be similar if we compared young and senescent birds, but is
inverted when comparing young and mature birds. Studies in humans show that females have a
stronger pro-inflammatory response to LPS than males via increased IL-6 and IL-10 [39]. In
female mice, macrophages produce as much as 50% more NO in response to an immune
challenge [38]. Male-Female differences have been attributed to sex hormones, notably estradiol,
differences in cytokine production and differences in acute phase proteins [37-39]. Female mice
produce higher levels of pro-inflammatory cytokines TNF-α, IL-1β and IL-6 in response to LPS
[37, 38]. Serum hormone levels, acute phase proteins and cytokine production were not
investigated in these experiments but the trend shows an increased sensitivity to LPS and NO
production in female chickens when compared with males. Thus the increases in NO production
by older, female chickens are explicable and likely due to parameters beyond the scope of these
experiments.
Increasing the abundance of all importers was sufficient for constitutive NO production,
but did not to increase LPS-induced NO production. These data indicate that increasing the
quantity of plasmid beyond 0.67 µg/mL does not increase the number of recoverable cells
positive for V5 epitope tagged protein(s). The amount of V5 tagged protein was not quantified,
thus it is possible that increased plasmid can increase protein production or increased plasmid
splits the transfection result between the different plasmids. The C-terminus of the transporters
containing the V5 epitope are intracellular, but extracellular domains may be degraded by the
trypsin solution used to detach the cells from their culture environment [25]. These partially
degraded proteins may not be accurately represented by α-V5 epitope antibody tagging.
Transfecting with non-transporter containing plasmids resulted in minor amounts of NO
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indicating that any plasmid, regardless of contents, may be recognized and induce a separate
immune response through TLR9 [41]. A TLR9 mediated response would antagonize the TLR4
response stimulated by LPS by interfering with the MAPKs and NF-κB signaling pathways [42].
Transfection with foreign sources of DNA or RNA has been shown to silence host transcription
and translation [43]. As such, the transient transfections may resemble sole expression of
transporter in question and not over-expression, hence why transfection with the all three CATs
results in an LPS induced response similar to mock transfection.
These experiments indicate that the respiratory burst mechanism in the chicken
macrophage can be mediated by CAT-1 or CAT-3. A maximal NO response is mediated by overexpressing CAT-1 and thus may provide a target for evaluating genetic differences in chicken
strains. Selective breeding of chickens for divergent purposes to maximize production capacity
has not altered the pattern of CAT changes between breeds observed in a NO response to LPS,
but instead shows indications of altering the magnitude of the response. Gram-negative bacteria
such as Salmonella pose significant financial risk to the poultry industry, especially in flocks of
layers. If increases in CAT-1 or CAT-3 can be correlated with increased pathogen clearance by
chicken macrophages, they could prove valuable targets for selective breeding.
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CHAPTER 3
Conclusions
5.1 Summary
CAT-1 and CAT-3 are both sufficient to provide for sustained NO production in the
absence of an immunogen. CAT-1 is induced in response to a simulated bacterial infection and
provides for a maximal NO response when over-expressed. These results indicate that respiratory
burst mechanisms in aves are mediated by multiple import-export systems unlike mammals that
depend on a single importer.
5.2 Future Studies
To further elucidate the role of each transporter in the complete NO response additional
trials need to be conducted using knock-out cells or siRNA to inhibit the importers. Additionally,
the biological significance of increasing or decreasing the magnitude of the respiratory burst
should be evaluated. The phagocytic and bactericidal effect of differing levels of NO production
would show the animal level value in eradicating infections from pathogens like Escherichia coli
and Salmonella spp. While an increased response might increase pathogen clearance, to dramatic
an increase in NO production can also cause oxidative damage to the host animal.
To further explore the issue of male-female and age related confounding factors, the
mRNA quantification should be replicated in small-scale age matched animals. Young sexed
broilers are available and could be raised concordantly with replacement layers and roosters to
suss out these interactions.
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Arginase II has been shown to regulate pathogenicity of Salmonella in mouse
macrophages by altering the fate of ARG [1]. Efforts to identify and sequence either arginase I or
II in the chicken macrophage have thus far been unsuccessful (data not shown).
5.3 Implications
These results show the potential to identify on a breed and/or gender basis the predicted
animal sensitivity and responsiveness to gram-negative bacterial challenges. While increased
innate immune activity may increase bird survival, it also negatively impacts performance. Thus
the task of identifying optimal immune responsiveness may remain a distant goal.
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APPENDIX
Figure 9. Representative image of ViaCount of HD11 cells on EasyCytePlus Flow cytometer.1

1

Abbreviations: FSC, forward scatter.
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Figure 10. Representative image of KUL01-PE of peripheral blood mononuclear cells on
EasyCytePlus Flow cytometer.1,2

1

Grey indicates KUL01-PE stained cells; black indicates cells not stained with KUL01.
Abbreviations: KUL01-PE, macrophage specific antibody conjugated to R-phycoerythrin.

2
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Figure 11. Representative V5-FITC staining image of transiently transfected HD11 cells on
EasyCytePlus Flow cytometer. 1,2

1

Grey indicates V5-FITC stained cells; black indicates cells not stained with V5.
Abbreviations: V5, transfect target epitope specific antibody conjugated to fluorescein.
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